New Atrial Fibrillation Drug Pradaxa Approved
The FDA has approved Pradaxa, a new drug to prevent blood clots in patients with atrial fibrillation.
Click here to read the full story.
No profanity or inappropriate comments will be allowed.
Offensive posters will be blocked from future postings.
The content has been reported and it will be reviewed by a moderator.